American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - Blood …, 2018 - ashpublications.org
In February 2022, these guidelines were reviewed by an expert work group convened by
ASH. Review included limited searches for new evidence and discussion of the search …
被引用次数：604 相关文章

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

A Cuker, GM Arepally, BH Chong, DB Cines… - Blood …, 2018 - europepmc.org
Background Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …
[HTML] nih.gov

[HTML][HTML] American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - Blood …, 2018 - ncbi.nlm.nih.gov
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …
[PDF] amedeolucente.it

[PDF][PDF] American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - 2018 - amedeolucente.it
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - Blood Advances, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> In February 2022, these guidelines were
reviewed by an expert work group convened by ASH. Review included limited searches for …
[PDF] uwhealth.org

[PDF][PDF] American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - 2018 - uwhealth.org
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - Blood Advances, 2018 - Elsevier
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …
[PDF] thebloodproject.com

[PDF][PDF] American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - 2018 - thebloodproject.com
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …
[PDF] amedeolucente.it

[PDF][PDF] American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - 2018 - amedeolucente.it
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong… - Blood …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated
by platelet-activating antibodies that target complexes of platelet factor 4 and heparin …